Stevens–Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stevens–Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 16, Issue 17, Pages 1989-2002
Publisher
Future Medicine Ltd
Online
2015-11-10
DOI
10.2217/pgs.15.128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Pharmacogenetics Study in Mozambican Patients Treated with Nevirapine: Full Resequencing of TRAF3IP2 Gene Shows a Novel Association with SJS/TEN Susceptibility
- (2015) Cinzia Ciccacci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association ofABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA,and BAG6polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy
- (2014) Xiao-Jing He et al. EPILEPSIA
- Clinical features of and genetic predisposition to drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients—investigating the relation between the HLA -B*4403 allele and lamotrigine
- (2014) Hye Jung Park et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Association ofHLA-B*1502allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis
- (2014) Tao Zeng et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations
- (2014) D. F. Carr et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells
- (2014) Chao Yang et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- HLA-B*58:01is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population
- (2013) M. Gonçalo et al. BRITISH JOURNAL OF DERMATOLOGY
- Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population
- (2013) Daniel F. Carr et al. CLINICAL INFECTIOUS DISEASES
- HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese
- (2013) Ying-Kit Cheung et al. EPILEPSIA
- HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique
- (2013) Paola Borgiani et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study
- (2013) Cinzia Ciccacci et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genotype–phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations
- (2013) Yi-Hsin Hsiao et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Toxic epidermal necrolysis
- (2013) Robert A. Schwartz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children
- (2013) Wiparat Manuyakorn et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- The role of Act1, a NF-κB-activating protein, in IL-6 and IL-8 levels induced by IL-17 stimulation in SW982 cells
- (2013) Fang Lv et al. PHARMACEUTICAL BIOLOGY
- HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
- (2013) E Genin et al. PHARMACOGENOMICS JOURNAL
- Detection of HLA-B*58:01, the susceptible allele for allopurinol-induced hypersensitivity, by loop-mediated isothermal amplification
- (2012) J. Kwok et al. BRITISH JOURNAL OF DERMATOLOGY
- CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction
- (2012) Balachandar Venkatesan et al. CELLULAR SIGNALLING
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
- (2012) M S Hershfield et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
- (2012) Chun-Yu Wei et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25
- (2012) Bo Zhong et al. NATURE IMMUNOLOGY
- HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
- (2012) Mayumi Ueta et al. PLoS One
- Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
- (2011) Jing Yuan et al. AIDS
- HLA-Dependent Hypersensitivity Reaction to Nevirapine in Chinese Han HIV-Infected Patients
- (2011) Shicheng Gao et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort
- (2011) Nicole Mittmann et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
- (2011) Ratchadaporn Somkrua et al. BMC Medical Genetics
- HLA-B*1502 genotyping in two Chinese patients with phenytoin-induced Stevens–Johnson syndrome
- (2011) Fu-Li Min et al. EPILEPSY & BEHAVIOR
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?
- (2011) M. H. Lee et al. INTERNAL MEDICINE JOURNAL
- Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
- (2011) Choong-Chor Chang et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- IL-17R signaling: new players get in on the Act1
- (2011) Michael J May NATURE IMMUNOLOGY
- HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency
- (2011) J.-W. Jung et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans
- (2011) Hye-Ryun Kang et al. Pharmacogenetics and Genomics
- A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients
- (2011) M Tohkin et al. PHARMACOGENOMICS JOURNAL
- Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders
- (2011) Mayumi Ueta et al. PLoS One
- Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity
- (2011) L. Kostenko et al. TISSUE ANTIGENS
- HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
- (2011) Kongkiat Kulkantrakorn et al. Pain Practice
- Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature
- (2010) K. E. Ward et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
- (2010) Nahoko Kaniwa et al. EPILEPSIA
- Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
- (2010) Wichittra Tassaneeyakul et al. EPILEPSIA
- Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
- (2010) Takeshi Ozeki et al. HUMAN MOLECULAR GENETICS
- Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study
- (2010) Mayumi Ueta et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients
- (2010) Mariko KASHIWAGI et al. JOURNAL OF DERMATOLOGY
- Stevens-Johnson syndrome induced by acetazolamide
- (2010) Young HER et al. JOURNAL OF DERMATOLOGY
- Common risk allele in aromatic antiepileptic-drug induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese
- (2010) Shuen-Iu Hung et al. PHARMACOGENOMICS
- HLA-B*5901is strongly associated with methazolamide-induced Stevens–Johnson syndrome/toxic epidermal necrolysis
- (2010) Sae-Hoon Kim et al. PHARMACOGENOMICS
- Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population
- (2010) Xiang-qing Wang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
- (2009) Hiroko Ikeda et al. EPILEPSIA
- Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population
- (2009) TW Mahungu et al. HIV MEDICINE
- Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians
- (2009) TimirY Mehta et al. Indian Journal of Dermatology Venereology & Leprology
- Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine
- (2009) G. Ramachandran et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients
- (2009) Gbenga R. Kazeem et al. Pharmacogenetics and Genomics
- Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population
- (2009) Wichittra Tassaneeyakul et al. Pharmacogenetics and Genomics
- HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients
- (2009) Sirirat Likanonsakul et al. AIDS Research and Therapy
- Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
- (2008) Chaichon Locharernkul et al. EPILEPSIA
- The clinical impact of pharmacogenetics on the treatment of epilepsy
- (2008) Wolfgang Löscher et al. EPILEPSIA
- A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
- (2008) Christine Lonjou et al. Pharmacogenetics and Genomics
- HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis
- (2008) Nahoko Kaniwa et al. PHARMACOGENOMICS
- Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
- (2008) P Brent Ferrell et al. PHARMACOGENOMICS
- Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
- (2007) Sima Halevy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started